Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer
Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9406-9427
Open Access | Times Cited: 13

Showing 13 citing articles:

From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors
Léa Berland, Zeina Gabr, Michelle Chang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1806-1806
Open Access | Times Cited: 5
Post-thoracotomy pain syndrome in the era of minimally invasive thoracic surgery
Takuro Miyazaki, Ryoichiro Doi, Keitaro Matsumoto
Journal of Thoracic Disease (2024) Vol. 16, Iss. 5, pp. 3422-3430
Open Access | Times Cited: 5
The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions
Angela Rina, Debora Maffeo, Francesca Minnai, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2882-2882
Open Access | Times Cited: 5
Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients
Anna Grenda, Ewelina Iwan, Barbara Kuźnar-Kamińska, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Prioritizing gut microbial SNPs linked to immunotherapy outcomes in NSCLC patients by integrative bioinformatics analysis
Muhammad Faheem Raziq, N. A. Khan, Haseeb Manzoor, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Dietary Trends, Microbiome, and Cardiovascular Health: A Narrative Review
Fabián Sanchis‐Gomar, Helios Pareja‐Galeano, José María Moya-Morales, et al.
Heart and Mind (2025)
Open Access
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability
Alba Moratiel Pellitero, María Zapata-García, Marta Gascón Ruiz, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1144-1144
Open Access | Times Cited: 3
Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-small Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
(2024)
Open Access | Times Cited: 2
Targeting the gut and tumor microbiome in cancer resistance
Sona Ciernikova, Aneta Sevcikova, Michal Mego
AJP Cell Physiology (2024) Vol. 327, Iss. 6, pp. C1433-C1450
Closed Access | Times Cited: 2
Biomarkers for immunotherapy resistance in non-small cell lung cancer
Catriona Rother, Thomas John, Annie Wong
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Understanding the relationship between breast cancer, immune checkpoint inhibitors, and gut microbiota: a narrative review
Gabriella Hrubesz, Jennifer Leigh, Terry L. Ng
Translational Breast Cancer Research (2024) Vol. 5, pp. 31-31
Closed Access
Page 1

Scroll to top